WO2003013351A1 - Medication personnelle et aide a la sante - Google Patents
Medication personnelle et aide a la sante Download PDFInfo
- Publication number
- WO2003013351A1 WO2003013351A1 PCT/SE2002/001431 SE0201431W WO03013351A1 WO 2003013351 A1 WO2003013351 A1 WO 2003013351A1 SE 0201431 W SE0201431 W SE 0201431W WO 03013351 A1 WO03013351 A1 WO 03013351A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- data
- input
- patient
- data processing
- storage means
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 229940079593 drug Drugs 0.000 title description 28
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 19
- 238000004422 calculation algorithm Methods 0.000 claims abstract description 11
- 230000036642 wellbeing Effects 0.000 claims abstract description 3
- 230000011664 signaling Effects 0.000 claims 1
- 230000003862 health status Effects 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 238000013480 data collection Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 206010013082 Discomfort Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000034308 Grand mal convulsion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
Definitions
- the present invention is for method, device and system for controlling the intake of medicine by a patient which can also be used to monitor critical health status for persons suffering from occasional onsets of potentially dangerous conditions.
- the person is examined at a doctors office and it is determined that the person suffers from a specific disorder and that the "un-well-ness" (or discomforts) that the patient is feeling is therefore determined to be a result of the diagnosed disorder.
- the person is then subjected to a spectrum of treatment options, primarily with the purpose of eliminating the disorder, and thus idealistically also its discomforts.
- the doctor After considering all the different factors the doctor arrives at a specific treatment plan, frequently incorporating a schedule with several drugs to be taken at various intervals Some drugs should be taken as regularly as possible to maintain a suitable concentration in the body. Sometimes the prescription might say "Up to x doses daily as needed” such as in the case of painkillers. Some times, there is interaction between food intake and certain drug functions, which ideally should be compensated for. The instructions to the user (patient) therefore tend to become fairly complicated, requiring relatively demanding intellectual efforts many times a day often at precise times. Since the patient usually is more or less taxed by the "un-well-ness" of his disease in addition to the demands of daily life and profession, this requirement in itself can easily become a critical burden and might even be an undesirable stress factor, contributing to the negative effects of the disorder.
- the patient usually receives an oral instruction and prescription to be filled by his pharmacy.
- the pharmacy he might also receive supplementary information and perhaps some general instruction sheets from the drug companies. Having tried to follow such instructions for a couple of months, usually a new visit to the doctors office is scheduled. This is the first occasion where the doctor is given an opportunity to evaluate the effectiveness of the plan by examining the patient, by test data follow-up (such as blood testing etc) and by personal interview, where the patient has an opportunity to describe his reactions and to provide information about how he feels about the effectiveness of the plan.
- An output parameter is defined that represents the actual control objective, such as a value representing a tool position, a temperature etc.
- An input parameter is defined representing the desired control objective; this could be a voltage, a knob handle position or a data value.
- the output parameter is compared to the input parameter.
- the enclosed figure is a diagram which illustrates the invention.
- Time delay is extremely long, weeks and months instead of minutes and hours.
- Representation of output parameter is extremely weak and based on a persons recollection of feeling, easily influenced by external factors (noise).
- the present invention includes a system improving at least on several of the above- mentioned factors that can relatively easily be improved, leaving "only” complicated and less understood factors to human evaluation.
- the system of the invention comprises the use of a device named Personal Medication Management Aid (PMMA) that is carried by the user at all times.
- PMMA Personal Medication Management Aid
- a device named Personal Medication Management Aid (PMMA) that is carried by the user at all times.
- PMMA Personal Medication Management Aid
- it has a medication container and an input device, typically a keyboard, and a display such as a numeric or alphanumeric/graphic display (similar to a pocket calculator or handheld palm computer). It also has an output device in the form of a beeper and/or vibrator. The output parameter would simply be represented by the user inputting a simplified "well-being index" on the keyboard.
- the PMMA also comprises a program algorithm stored in suitable means, specific to each type of illness, and individually parameterised by the doctor or other person having suitable skills and knowledge (corresponding to drug administration schedule).
- This program signals the user when he has to take the various drugs. After acknowledging drug intake, he also punches in his wellness factor.
- the algorithm is applied to the accumulating data, calculating modified timing information, in small steps and within doctor's limits, trying to continually improve drug usage profile.
- the PMMA measuring system can also be used to monitor the onset of undesired, but until now often unavoidable, dramatic conditions, such as insulin chock or epilepsy grand mal seizures.
- the difference being that the conditions, or rather the combined development of the measured parameters are monitored and compared to a different algorithm, pre-programmed and based more on the scientific knowledge and less on manual input.
- warnings are issued initially to the patient only.
- Even if the alarm conditions are pre-programmed there should be a continuous recording loop that is stopped if an actual seizure occurs. The data in the loop should then be transferred and analysed, eventually providing better understanding of actual process leading to seizure thereby allowing even individual improvement of prediction algorithms.
- This alarm signal should preferably be used to trigger lalarm conditions that are transmitted for instance via mobile phone system together with relevnt data and location information (such as obtained from the GPS system).
- the PMMA is brought into the doctor's office at regular visits where it is connected to their PC and analysed by the physician. When leaving the office, this data, together with all other findings has resulted in new parameters being programmed into the device and automatically continuing its cycle of medication management.
- the system is improved when relevant output information can be measured instead of estimated.
- Pulse measurement technology is available in common so-called sports watches generally based on electrical signals or by optically measuring tissue transparency changes. (Ear lobe or finger tip transducers commonly available, other systems possible). Information may be transmitted using e.g. commercially available chest belt (r. f.) transmitters or by acoustic means. (As commonly performed with stethoscopes when blood pressure is being measured).
- Blood pressure can be foreseen to be available in a robust "finger ring" shortly. Skin resistance (sweating, stress level) and temperature is easily measured. Blood oxygenation can also be measured relatively conveniently. Development is under way to measure glucose levels with non-invasive technology, which should be useful with the present system.
- Symptom specific parameters such as in the case of Parkinson's Disease, rigidness and or shakiness can at least be indicated by accelerometers or by a simple system with an on-board microphone and a small ball in a tiny compartment; when totally silent - patient is "frozen", when noisy patient is shaking etc.
- EMG signals muscle nerve impulses
- EEG waveform pattern can presumably reveal common side effects as sleep apnea.
- a breathing/ sneezing/ snoring indicator is foreseeable. (Asthma and other allergic ailments).
- the PMMA is daily connected to a home PC, either via a "cradle” such as commonly used with palm computers or via IR or RF (Bluetooth).
- a "cradle” such as commonly used with palm computers or via IR or RF (Bluetooth).
- IR or RF Bluetooth
- the PC can host a more sophisticated algorithm and database.
- the PC On the next system level the PC in turn uploads/downloads information directly to the doctors office via standard internet connections.
- the doctors computer would be provided with "pattern recognition" software, or other software using numerical mathematical methods, that would allow him to monitor patients progress and also to receive generated warnings if dangerous or undesireable conditions seem to be evolving. The doctor could also intervene in the optimisation process and influence timing parameters directly from his office.
- a further advantage is that information from a number of patients may put together and taken into account in the revision of individual algorithms.
- a preferred embodiment of the invention would be to use a commercially available wrist computer clock for data storage calculation and communication.
- the actual data collection signal treatment and data reduction would in this case be performed by a physically separate unit preferably mounted together with the main unit/wrist computer to facilitate data exchange.
- Such a configuration should not be seen as limiting the scope of the invention.
- Several other embodiments are possible or preferred in specific cases. Such embodiments would include the total integration of all parts together with the main unit. In this case the main unit would have to be positioned at a suitable place in contact with the body where the measured conditions are conveniently detectable.
- An alternative solution is to locate the main unit where it is easily accessible by the user and accepting various data collection satellite units remotely connected to the main unit or a sub-unit by wires, radio frequency or infrared transmitting links etc.
- the data collection unit has to communicate with the main unit to receive commands and transmit data.
- the communication takes place over the standardised ir-link.
- the ir-link is preferred even if the distance between the units is very small, only a few millimetres, in order to avoid possible long time contact integrity problems foreseen in virtually unknown external conditions. Since the IR system is standardised and commonly used it makes the system less dependent on the continued availability of a particular model of wrist or other computer.
- the universal system herein named MedClock system
- MedClock system is based on a data logging and communications module, the Med Clock.
- the MedClock is designed to be carried 24 hours a day with design emphasis on ease of use, understandability, discreteness etc.
- a number of physical parameters are measured and recorded such as heart rate, temperature, skin resistance and acceleration. These parameters are combined with user inputs such as subjective well being, sleepiness, functionality in specific jobs etc.
- the data is combined according to specific algorithms residing in the unit and specific output is calculated according to the various applications. Data is exchanged with PC on a regular basis, through suitable communications channels such as IR, wire connection, RF etc. In certain of these applications, specifically those with warning and alarm functions, output can be forwarded to a mobile phone or other similar long distance non-wire system (r.f. Ian etc), in specific cases combined with GPS or other location data, to allow for emergency assistance when the unit detects an alarm condition. Data is also recorded into databases, either locally on PC or for instance on a health providers web system.
- the data so recorded is used to assist physician in detecting undesirable conditions. It is also the basis for a more sophisticated analysis to provide improved medical strategies. It will also allow data streams from several groups of patients to be of benefit to all patients. Suitably de-personalized these files would provide valuable research data.
- the various MedClock versions are all differently configured for their specific application. The examples listed below indicate the universal opportunities to configure the device to serve the specific needs of an individual or group. Obviously with all these applications requiring different software, but using the same hardware, the software programming environment becomes important.
- a tool to assist in documenting results of various therapies More geared toward data collection than continuos medical support. Will be useful to establish a new patient's initial data for a specific illness.
- a research tool Adaptable to specific research.
- a researchers programming package should be provided.
- an automatic selective emergency alarm system is provided.
- a further step would be to actually prevent machine or vehicle operation by a potentially sleepy driver.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102694A SE0102694L (sv) | 2001-08-08 | 2001-08-08 | Personligt hjälpmedel för hantering av medicin |
| SE0102694-7 | 2001-08-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2003013351A1 true WO2003013351A1 (fr) | 2003-02-20 |
Family
ID=20285010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/SE2002/001431 WO2003013351A1 (fr) | 2001-08-08 | 2002-08-07 | Medication personnelle et aide a la sante |
Country Status (2)
| Country | Link |
|---|---|
| SE (1) | SE0102694L (fr) |
| WO (1) | WO2003013351A1 (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004027674A1 (fr) * | 2002-09-20 | 2004-04-01 | Neurotech Research Pty Limited | Analyse d'etat |
| JP2008541307A (ja) * | 2005-05-18 | 2008-11-20 | エーシーケー ベンチャーズ ホールディングス エルエルシー | コンテンツの予約 |
| CN106963568A (zh) * | 2017-04-06 | 2017-07-21 | 湖北纪思智能科技有限公司 | 带有健康监测系统的智能轮椅 |
| US10565329B2 (en) | 2014-06-30 | 2020-02-18 | Evolving Machine Intelligence Pty Ltd | System and method for modelling system behaviour |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672154A (en) * | 1992-08-27 | 1997-09-30 | Minidoc I Uppsala Ab | Method and apparatus for controlled individualized medication |
| WO2000032088A1 (fr) * | 1998-11-30 | 2000-06-08 | Novo Nordisk A/S | Systeme medical et procede de commande d'un systeme utilise par un patient pour s'auto-traiter |
| DE10004496A1 (de) * | 2000-02-02 | 2000-08-03 | Meonic Sys Eng Gmbh | Vorrichtung und Verfahren zur Injektion eines Medikamentes |
| WO2000067185A1 (fr) * | 1999-05-05 | 2000-11-09 | Healthgram, Inc. | Dossier de sante portable |
-
2001
- 2001-08-08 SE SE0102694A patent/SE0102694L/xx not_active Application Discontinuation
-
2002
- 2002-08-07 WO PCT/SE2002/001431 patent/WO2003013351A1/fr not_active Application Discontinuation
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672154A (en) * | 1992-08-27 | 1997-09-30 | Minidoc I Uppsala Ab | Method and apparatus for controlled individualized medication |
| WO2000032088A1 (fr) * | 1998-11-30 | 2000-06-08 | Novo Nordisk A/S | Systeme medical et procede de commande d'un systeme utilise par un patient pour s'auto-traiter |
| WO2000067185A1 (fr) * | 1999-05-05 | 2000-11-09 | Healthgram, Inc. | Dossier de sante portable |
| DE10004496A1 (de) * | 2000-02-02 | 2000-08-03 | Meonic Sys Eng Gmbh | Vorrichtung und Verfahren zur Injektion eines Medikamentes |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004027674A1 (fr) * | 2002-09-20 | 2004-04-01 | Neurotech Research Pty Limited | Analyse d'etat |
| AU2003260191B2 (en) * | 2002-09-20 | 2009-10-01 | Neurotech Research Pty Limited | Condition analysis |
| US8626522B2 (en) | 2002-09-20 | 2014-01-07 | Neurotech Research Pty. Ltd. | Condition analysis |
| JP2008541307A (ja) * | 2005-05-18 | 2008-11-20 | エーシーケー ベンチャーズ ホールディングス エルエルシー | コンテンツの予約 |
| US10565329B2 (en) | 2014-06-30 | 2020-02-18 | Evolving Machine Intelligence Pty Ltd | System and method for modelling system behaviour |
| US12026438B2 (en) | 2014-06-30 | 2024-07-02 | Evolving Machine Intelligence Pty Ltd | System and method for modelling system behaviour |
| CN106963568A (zh) * | 2017-04-06 | 2017-07-21 | 湖北纪思智能科技有限公司 | 带有健康监测系统的智能轮椅 |
Also Published As
| Publication number | Publication date |
|---|---|
| SE0102694L (sv) | 2003-02-09 |
| SE0102694D0 (sv) | 2001-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU765742B2 (en) | A method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions | |
| EP1437674B1 (fr) | Procédé permettant à un utilisateur de s'administrer seul son traitement médical | |
| AU2002229926B2 (en) | A personal condition management system | |
| Ouchi et al. | LifeMinder: a wearable healthcare support system using user's context | |
| US20090216132A1 (en) | System for Continuous Blood Pressure Monitoring | |
| US20030144829A1 (en) | System and method for sensing and evaluating physiological parameters and modeling an adaptable predictive analysis for symptoms management | |
| US20230245741A1 (en) | Information processing device, information processing system, and information processing method | |
| Glaros et al. | Wearable devices in healthcare | |
| WO2010022387A1 (fr) | Procédé et appareil de lutte contre les maladies chroniques | |
| WO2018235652A1 (fr) | Dispositif de gestion de santé, procédé de gestion de santé et programme de gestion de santé | |
| KR20190061826A (ko) | 외상 후 스트레스 장애 및 공황장애 치료를 위한 복합 생체 정보 검출 시스템 및 방법 | |
| US20220280105A1 (en) | System and method for personalized biofeedback from a wearable device | |
| US11721421B2 (en) | Pharmaceutical dispensing system | |
| JP2004503284A (ja) | 身体活動の測定及び分析用システム | |
| KR102767004B1 (ko) | 건강 정보 분석 기반의 약물의 복용 관리 시스템 및 방법 | |
| WO2003013351A1 (fr) | Medication personnelle et aide a la sante | |
| KR102028685B1 (ko) | 병원 업무 중개 방법, 시스템 및 프로그램 | |
| US11116455B2 (en) | Diagnostic assistance device, vital signs information measuring device, and diagnostic assistance method | |
| Perillo et al. | Enhanced Home Elderly Care: integrating Fitbit technology within Android Studio evolutionary prototypes | |
| JP7555940B2 (ja) | 治療的処置の実施または行為を支援するための方法 | |
| US20250218589A1 (en) | Hydration Managing System | |
| JP6117497B2 (ja) | 生体情報管理システム及び生体情報管理方法 | |
| EP4312228A1 (fr) | Système de soutien au contrôle de santé d'un patient et procédé de fonctionnement d'un tel système | |
| Ramani et al. | GuardianMeds: Empowering Elderly Care with IoT Medication Monitoring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ PH PL PT RO SD SE SG SI SK SL TJ TM TR TT TZ UG US UZ VN YU ZA Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |